Insight | Thought Leadership

Life Sciences Business Evolution Series: Funding Growth and the Future of Life Sciences

Life sciences companies intend to leverage new and existing sources of growth including through M&A, carve-outs, divestitures, partnerships, licensing and collaboration agreements as well as avenues tied to corporate PPAs and green financing. Find out about these trajectories as well as continued VC investment and increasing appetite from private equity sponsors in pre-revenue stages.
Read More

We are one of the world’s most active law firms in the pharmaceutical, biotech and medical device spaces. Our extensive geographic footprint, coupled with a single point of contact, makes us the go-to law firm for various global matters. Our life sciences transactions team has significant experience in the following areas:

Collaborations and Licensing

  • Complex multinational collaborations
  • Joint ventures
  • Commercialization agreements
  • Co-promotion agreements
  • Research and development agreements
  • Evaluation and option agreements


  • Product acquisitions and divestitures
  • Company sales and acquisitions
  • Business unit spinoffs
  • Post-acquisition integration


  • Equity financing
  • Royalty monetization
  • Development funding agreements

Operational Agreements

  • Manufacturing and supply agreements
  • Distribution agreements
  • Services agreements
  • University and other nonprofit agreements